1. Home
  2. FORTY vs FTRE Comparison

FORTY vs FTRE Comparison

Compare FORTY & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Formula Systems (1985) Ltd.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$114.99

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$19.73

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORTY
FTRE
Founded
1985
1996
Country
Israel
United States
Employees
19337
14000
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
1998
2023

Fundamental Metrics

Financial Performance
Metric
FORTY
FTRE
Price
$114.99
$19.73
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
★ $14.06
AVG Volume (30 Days)
2.1K
★ 1.2M
Earning Date
05-21-2026
05-05-2026
Dividend Yield
★ 1.32%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,723,400,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$3.09
P/E Ratio
$36.65
★ N/A
Revenue Growth
N/A
★ 1.00
52 Week Low
$102.01
$8.31
52 Week High
$190.56
$21.39

Technical Indicators

Market Signals
Indicator
FORTY
FTRE
Relative Strength Index (RSI) 48.29 56.37
Support Level $109.49 $15.77
Resistance Level $119.68 $21.25
Average True Range (ATR) 1.67 0.96
MACD 0.09 0.12
Stochastic Oscillator 34.78 72.21

Price Performance

Historical Comparison
FORTY
FTRE

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.

Share on Social Networks: